Historial del iniciado Otro Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Browse the full record of transactions filed by Deborah Waterhouse. Director active across 1 company, notably GSK plc. Aggregated, 104 disclosures have been logged. History available since 9 August 2023. The latest transaction was filed on 11 August 2026 (Purchase). Regulator: RNS (LSE). The full history is openly available.
Companies and markets linked to Deborah Waterhouse Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 104 en total
● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 11 ago 2026 · GSK plc 14 títulos @ 19,3493 GBP London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9721245-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 11 ago 2026 · GSK plc 14 títulos @ 19,3493 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63FCA-NSM:802aebe3-75c1-4ba5-8333-3c8ccb6de1b0-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 10 jul 2026 · GSK plc 867 títulos @ 19,595 GBP 0.0022% mcap 0.1% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9668630-22 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 jul 2026 · GSK plc 1070,064 títulos @ 19,6297 GBP 0.0027% mcap 0.1% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9668630-9 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 jul 2026 · GSK plc 0
London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:0920c70b-f075-4c99-aba0-46720a29730a-9 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 jul 2026 · GSK plc 12 títulos @ 19,6292 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9666294-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 jul 2026 · GSK plc 58 títulos @ 19,629 GBP 0.0001% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9666294-15 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 jul 2026 · GSK plc 12 títulos @ 19,6292 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 jul 2026 · GSK plc 58 títulos @ 19,629 GBP 0.0001% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-15 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 jun 2026 · GSK plc 14 títulos @ 18,8393 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9614374-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 jun 2026 · GSK plc 14 títulos @ 18,8393 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:03338973-0058-4811-9fe5-7b22157346a2-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 12 may 2026 · GSK plc 12 títulos @ 18,778 GBP 0.0000% mcap 100.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9569357-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 12 may 2026 · GSK plc 12 títulos @ 18,6558 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:eaad27f1-a91f-4bc4-815a-149202956de0-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 14 abr 2026 · GSK plc 824 títulos @ 21,67 GBP 0.0000% mcap 0.1% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-8 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 13 abr 2026 · GSK plc 12 títulos @ 21,7083 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:bae2311e-28b0-4835-a894-0209eedccba9-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 abr 2026 · GSK plc 0
London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-13 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 abr 2026 · GSK plc 56 títulos @ 21,3387 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-7 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 10 mar 2026 · GSK plc 12 títulos @ 20,7167 GBP 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-6 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 13 feb 2026 · GSK plc 76.587 títulos @ 21,6002 GBP 9.7% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-23 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 13 feb 2026 · GSK plc 162.949 títulos 0
N/AISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-22 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 12 feb 2026 · GSK plc 18.543 títulos @ 21,50 GBP 2.3% de su flujo N/AISIN ISIN GB00BN7SWP63RNS:6207777f-2477-470b-868f-21f92714189a-8 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 12 feb 2026 · GSK plc 136.579 títulos @ 21,50 GBP 17.3% de su flujo N/AISIN ISIN GB00BN7SWP63RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-12 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 feb 2026 · GSK plc 21.009 títulos @ 22,0267 GBP 2.7% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-15 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 10 feb 2026 · GSK plc 0
N/AISIN ISIN GB00BN7SWP63RNS:8df504c6-f415-410b-a190-e5ddcfc0debe-2 ● CEO, ViiV Healthcare and President, Global Health, GSK · Directivos · 9 feb 2026 · GSK plc 44.631 títulos 0
N/AISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-14 25 de 104 declaraciones
Ver más (79 restantes) About Deborah Waterhouse Deborah Waterhouse is a declarant linked to GSK plc, where the listed role is CEO, ViiV Healthcare and President, Global Health, GSK. She has 94 filings in total, and among the sampled recent filings from 2023-08-10 to 2026-06-12, purchases amount to EUR 22,690 and sales to EUR 8,811,372.